{{Rsnum
|rsid=13143308
|Gene=LOC729065
|Chromosome=4
|position=110793263
|Orientation=plus
|GMAF=0.4082
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 57.6 | 37.3 | 5.1
| HCB | 13.5 | 43.2 | 43.2
| JPT | 2.8 | 52.8 | 44.4
| YRI | 38.9 | 46.3 | 14.8
| ASW | 0.0 | 0.0 | 0.0
| CHB | 13.5 | 43.2 | 43.2
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs13143308
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:20031626
|Annotation=The minor allele of rs13143308 is associated with increased risk for postoperative Atrial Fibrillation. Risk or phenotype-associated allele: minor allele( nucleotide unspecified). Phenotype: increased risk for postoperative Atrial Fibrillation. Study size: Discovery cohort: 959; Validation cohort: 494. Study population/ethnicity: Patients ages 21-90 who underwent Coronary Artery Bypass Graft Surgery at Brigham and Women&apos;s Hospital or at Texas Heart Institute. Significance metrics: OR = 1.76; 95% CI = 1.23-2.52; p = 0.002. Type of association: CO; GN;
|Drugs=
|Drug Classes=
|Diseases=Atrial Fibrillation
|Curation Level=Curated
|PharmGKB Accession ID=PA165111454
}}

{{PMID Auto
|PMID=20606429
|Title=Association of RS2200733 but not RS10033464 on 4q25 with atrial fibrillation based on the recessive model in a Taiwanese population.
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs13143308
|overall_frequency_n=80
|overall_frequency_d=128
|overall_frequency=0.625
|n_genomes=45
|n_genomes_annotated=0
|n_haplomes=66
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}